Too Much Carrot and Not Enough Stick in New Stem Cell Oversight Trends.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29937201.
- Also identified by DOI 10.1016/j.stem.2018.06.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Regulators are now more often distinguishing between perceived good citizens and "bad actors" in stem cell and regenerative medicine clinical research, resulting in relatively more polar, carrot-and-stick oversight approaches. Here, I discuss why there may be too much carrot and not enough stick by regulators for effective enforcement.
Medical subject headings
- Stem Cell Transplantation
- Stem Cells